Innovist Secures $7M Funding to Boost D2C Brands

Innovist Secures $7M Funding to Boost D2C Brands

Innovist, the parent company behind popular consumer brands like Bare Anatomy and Chemist at Play, has successfully raised a hefty $7 million in its recent Series A funding round.

This funding round was led by the Amazon Smbhav Venture Fund, with significant participation from existing backers including 72 Ventures, the investment firm linked to Nykaa founder Falguni Nayar and former KKR India head Sanjay Nayar.

Established back in 2018 by Rohit Chawla, Sifat Khurana, and Vimal Bhola, Innovist, previously known as Onesto Labs, specializes in offering a range of personal care products.

With this infusion of funds, Innovist, the proud owner of three distinct brands – Bare Anatomy, Chemist at Play, and SunScoop, is gearing up for a surge in product innovation, widening its market reach, and expanding its talented team.

This round of funding follows a successful streak for Innovist. In the previous year, it secured $3.5 million in its pre-Series A funding, led by Accel Partners and 72 Ventures, after previously obtaining $2.5 million in 2021.

This fresh injection of capital marks a significant milestone for Innovist, propelling its mission to further enhance its product offerings and extend its presence in the market.

Picture of KeeVurds Desk

KeeVurds Desk

KeeVurds editorial team is a group of writers, journalists, and editors who are interested and passionate about global startup and business economy. At KeeVurds, we follow strict guidelines to publish and share unbiased and well-researched content that helps startup founders and rising entrepreneurs.

Leave a Reply

Your email address will not be published. Required fields are marked *

Powered By - Apna Writer

We have partnered with Apna Writer, one of the leading content writing agencies based out of India.
Scroll to Top